Close

Lawsuit Challenges New Arkansas Mandate Requiring Employers and Consumers Pay Higher Rates to Drug

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

LifeSignals launches UbiqVueTM Holter System in partnership with UltraLinQ at Heart Rhythm 2025

Milpitas, California, USA:  LifeSignals, Inc. today announced the launch...

AvaSure Acquires Nurse Disrupted to Advance Clinically-Developed Virtual Nursing Across Care Settings

BELMONT, Mich.--(BUSINESS WIRE)--AvaSure, the leader in AI-powered virtual care...
The Pharmaceutical Care Management Association (PCMA), the national association epresenting America's pharmacy benefit managers (PBMs), has filed a lawsuit in Arkansas challenging a new law requiring employers to pay higher rates to drugstores for prescription drugs.  Arkansas is the only state with such a law that is a "blank check" to drugstores.

PBMs administer prescription drug plans for more than 246 million Americans who have health coverage through commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.

"At a time when people are concerned about rising health costs, this new law forces employers and consumers to pay drugstores higher rates for prescription drugs," said PCMA President and CEO Mark Merritt.

The law—Arkansas 900—mandates that employers reimburse drugstores higher rates for prescription drugs, removing incentives for drugstores to dispense lower-priced options.

Specifically, Arkansas 900 will:

  •     Force employers and consumers to pay drugstores more for prescription drugs.
  •     Require employers and consumers to pay each pharmacy at or above its cost to acquire drugs, even when the same drugs are available at lower costs in the marketplace.
  •     Entitle drugstores to appeal contract payments if they claim each individual past reimbursement was not large enough.
  •     Incentivize drugstores to charge higher prices for generic drugs.
  •     Empower drugstores to deny patients their medications if the drugstore determines it is not being paid enough.

Latest stories

Related stories

LifeSignals launches UbiqVueTM Holter System in partnership with UltraLinQ at Heart Rhythm 2025

Milpitas, California, USA:  LifeSignals, Inc. today announced the launch...

AvaSure Acquires Nurse Disrupted to Advance Clinically-Developed Virtual Nursing Across Care Settings

BELMONT, Mich.--(BUSINESS WIRE)--AvaSure, the leader in AI-powered virtual care...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back